TipRanks
Adaptive Biotechnologies Corp (ADPT)
NASDAQ:ADPT
US Market
ADPT
Adaptive Biotechnologies
RESEARCH TOOLSreports
Want to see ADPT full AI Analyst Report?

Adaptive Biotechnologies (ADPT) Stock News & Sentiment

1,091 Followers
ADPT, MRNA, CRWV, NBIS, JAZZ trending with analysts
Premium
Weekend Updates
ADPT, MRNA, CRWV, NBIS, JAZZ trending with analysts
11d ago
ADPT
CRWV
Analyst Raises Adaptive’s Price Target to $34 on Strengthening clonoSEQ MRD Adoption and NCCN Guideline Support
Premium
Ratings
Analyst Raises Adaptive’s Price Target to $34 on Strengthening clonoSEQ MRD Adoption and NCCN Guideline Support
22d ago
ADPT
Analyst Reaffirms Buy on Adaptive Biotechnologies, Lifting Price Target to $25 Amid Strong MRD Momentum and Raised 2026 Guidance
Premium
Ratings
Analyst Reaffirms Buy on Adaptive Biotechnologies, Lifting Price Target to $25 Amid Strong MRD Momentum and Raised 2026 Guidance
3M ago
ADPT
Adaptive Biotechnologies Earns Buy Rating as Strong MRD-Driven Revenue Beat and Margin Expansion Support Attractive Risk-Reward
Premium
Ratings
Adaptive Biotechnologies Earns Buy Rating as Strong MRD-Driven Revenue Beat and Margin Expansion Support Attractive Risk-Reward
3M ago
ADPT
Adaptive Biotechnologies CSO Transitions to Strategic Consulting Role
Premium
Company Announcements
Adaptive Biotechnologies CSO Transitions to Strategic Consulting Role
3M ago
8K
ADPT
Adaptive Biotechnologies Issues Convertible Notes to Reshape Capital
Premium
Company Announcements
Adaptive Biotechnologies Issues Convertible Notes to Reshape Capital
4M ago
8K
ADPT
Adaptive Biotechnologies Plans MRD and Immune Medicine Split
Premium
Company Announcements
Adaptive Biotechnologies Plans MRD and Immune Medicine Split
4M ago
8K
ADPT
More ADPT News >

ADPT News on the Web

Adaptive Biotechnologies (ADPT) Chief Commercial Officer Susan Bobulsky Sells 6,444 Shares
GuruFocus News
Neutral
ADPT, MRNA, CRWV, NBIS, JAZZ trending with analysts
TipRanks News
Bullish
Adaptive Biotechnologies Consensus Price Target Increased by 11.11% to $28.05
Fintel
Bullish
Adaptive Biotechnologies Stock Stumbles After Hot Rally
TipRanks News
Neutral
Adaptive Biotechnologies (ADPT): Can Blood Cancer Guidelines Boost Repeat Testing?
Insider Monkey
Neutral
Adaptive Biotechnologies (ADPT) Chief Commercial Officer Susan Bobulsky Sells 1,195 Shares
GuruFocus News
Neutral
Adaptive Biotechnologies Corporation at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
Director Katey Owen Sells 9,615 Shares of Adaptive Biotechnologies Corp (ADPT)
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
ADPT
Sector Average
Media Buzz
This Week3 articles
Weekly Average4.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ADPT’s Media Buzz Sentiment?
3 articles about ADPT were published this week. In an average week, 4.75 articles are published.
    What is ADPT’s weekly average amount of articles?
    In an average week, 4.75 articles about ADPT are published.
      What is ADPT’s News Sentiment?
      100% of articles about ADPT were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        GKOSGlaukos
        RYTMRhythm Pharmaceuticals
        DHRDanaher
        HALOHalozyme
        VRTXVertex Pharmaceuticals
        Showing the stocks with the most bullish news sentiment over the past week